2. Introduction
Study of genetic variations that influence individual response
to drug.
Relatively new field, combines pharmacology (the science of
drug) and genomics(the study of genes and their functions) to
develop effective, safe medications and doses that will be
tailored to a person’s genetic makeup.
4. Choosing the right drug-
Abacavir
Nucleoside Reverse Transcriptase Inhibitor (NRTI) for
treatment of HIV.
Hypersensitivity reaction:
• rash and/or fever
• abrupt onset of vomiting/nausea/diarrhoea
• respiratory symptoms: tachypnea, cough and pharyngitis
HLA‐B*5701 allele has demonstrated a positive predictive
value for the development of hypersensitivity reaction.
Occurs at a frequency of around 5% in Europeans, 1% in
Asians and <1% in Africans.
Test for HLA‐B*5701 prior to beginning of abacavir.
5.
6. Predicting adverse drug
reactions- Warfarin
Warfarin is an anti-coagulant, an agent that prevents blood
clots forming.
Used in the prevention and treatment of thrombotic
disorders.
Too low dosage shows no effect.
High dosage may lead to internal bleeding (haemorrhaging).
Warfarin activity is determined partially by genetic factors.
Polymorphisms in two genes (VKORC1 and CYP2C9) play a
particularly large role in response to warfarin.
7.
8.
9. Benefits of
pharmacogenomics
Predict patient’s response to
drug and develop customized
prescriptions.
Minimize or eliminate adverse
events.
More accurate method of
determining dosage.
Better, safer drug at the first
time.